News & Updates
Filter by Specialty:
Stroke risk elevated first 3 days post–COVID-19 diagnosis
Older patients with COVID-19 may have an increased risk of being hospitalized for acute ischaemic stroke (AIS), particularly in the first 3 days following their COVID-19 diagnosis, according to a study presented at ISC 2022.
Stroke risk elevated first 3 days post–COVID-19 diagnosis
18 Feb 2022IM noninferior to IV sotrovimab for COVID-19
In high-risk nonhospitalized patients with mild-to-moderate COVID-19, intramuscular administration of the monoclonal antibody sotrovimab was noninferior to IV infusion of the drug, according to findings from the phase III COMET-TAIL trial presented at CROI 2022.
IM noninferior to IV sotrovimab for COVID-19
17 Feb 2022COVID-19 infection relatively rare in vaccinated IBD patients
Patients with inflammatory bowel disease (IBD) who have completed a COVID-19 vaccine regimen have a low risk of developing COVID-19, though receipt of mRNA vaccines may offer better protection, according to a small study presented at the Crohn’s and Colitis Congress 2022.
COVID-19 infection relatively rare in vaccinated IBD patients
15 Feb 2022Extensive influenza testing needed in pneumonia patients
Most patients with community-acquired pneumonia go untested for influenza even during flu season, which is unfortunate since a positive test result facilitates antiviral therapy, and early treatment leads to lower mortality, according to a study.
Extensive influenza testing needed in pneumonia patients
10 Feb 2022Casirivimab-imdevimab combo prevents progression from asymptomatic to symptomatic COVID-19
Treatment with the combination therapy of casirivimab and imdevimab prevents the risk of developing symptomatic COVID-19 among asymptomatic individuals with SARS-CoV-2 infection in a household close-contact setting, according to a recent study.
Casirivimab-imdevimab combo prevents progression from asymptomatic to symptomatic COVID-19
10 Feb 2022CPAP reduces tracheal intubation, mortality in adults with COVID-19–related acute hypoxemic respiratory failure
The use of continuous positive airway pressure (CPAP) significantly reduces the risk of tracheal intubation and mortality among hospitalized patients with COVID-19–related acute hypoxemic respiratory failure, according to the RECOVERY-RS* trial.